Page 1

R RYMAN HEALTHCARE Results for announcement to the market Name of issuer Ryman Healthcare Limited Reporting Period Year to 31 March 2021 Previous Reporting Period Currency Year to 31 March 2020 NZD Amount ( 000s ) Percentage change Revenue from continuing operations $ 452,411 7.2 % Fair value movement of investment $ 416,847 188.6 % properties Total income $ 872,641 53.5 % Net profit / ( loss ) from continuing $ 423,061 59.8 % operations Total net profit / ( loss ) $ 423,061 59.8 % Underlying profit ( non - GAAP ) - - see $ 224,449 -7.3 % explanation below Interim / Final Dividend Amount per Quoted Equity Security 13.6 cents Imputed amount per Quoted Equity Not imputed Security Record Date 4 June 2021 Dividend Payment Date 18 June 2021 Current period Prior comparable period 557.4 452.6 Net tangible assets per Quoted Equity Security ( cents per share ) A brief explanation of any of the figures above necessary to enable the figures to be understood Underlying profit is a non - GAAP ( Generally Accepted Accounting Principles ) measure and differs from NZ IFRS profit for the year . Underlying profit does not have a standardised meaning prescribed by GAAP and so may not be comparable to similar financial information presented by other entities . The Group uses underlying profit , with other measures , to measure performance . Underlying profit is a measure that the Group uses consistently across reporting periods . Underlying profit includes realised movement on investment property for units in which a right - to - occupy has been sold during the period and for which a legally binding contract is in place at the reporting date . The occupancy advance for these units may have been received or be included within the trade receivables balance at reporting date .